Molecular footprints in lung cancer diagnosis and management

Symposium
Chairs: Jean-Paul Sculier (Brussels, Belgium), Tariq Sethi (Haddington, United Kingdom)
Aims: To examine the evidence behind current perceptions of molecular biomarkers, genetics, and genomics in thoracic oncology; to provide an overview of the cutting-edge research in terms of lung cancer treatment.

Molecular predictors of disease progression: have we made any progress? Torsten Gerriet Blum (Berlin, Germany)
Discovery of new drugs in thoracic oncology Anne-Marie Dingemans (Masstricht, Netherlands)
Lung cancer: what are the genetic and genomic perspectives? Kwun Fong (Brisbane, Australia)
Stem cells and lung cancer treatment: any hope? Sam Janes (London, United Kingdom)